Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency

This study has been completed.
Sponsor:
Collaborator:
University of Yaounde
Information provided by:
Health Enhancement Products, Inc.
ClinicalTrials.gov Identifier:
NCT00493506
First received: June 26, 2007
Last updated: June 27, 2007
Last verified: June 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2006
  Estimated Primary Completion Date: No date given